Samrotecan
Highest phase reached
Phase 1
Drug type
Small molecule
- Listing at source
- Listed
- Highest phase reached
- Phase 1
- Drug type
- Small molecule
- Drug name
- Samrotecan
- Structure (SMILES)
- O=c1n2c(-c3c(c4c5c(n3)ccc(NC([C@@H](NC([C@@H](NC(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(CCN6C(=O)C=CC6=O)=O)=O)C(C)C)=O)C)=O)c5CCC4)C2)cc7c1COC(=O)[C@@]7(CC)O
- az 14170133
- AZ-14170133
- az14170133
- AZ14170133
- samrotecan
- Samrotecan
- SAMROTECAN [USAN]
- samrotecan usan
- sg 3932
- SG-3932
- sg3932
- SG3932
- CAS registry numbers
- 2495742-34-0
- ChEMBL ID
- CHEMBL6068471
- InChIKey
- OYYHJMUXFQIRBT-ZHSICCDKSA-N
- PubChem compound IDs
- 155142254
- FDA ingredient codes (UNII)
- J7299D2YCZ
- First in class
- No
- Orphan designation
- No
- Drug name stem
- -tecan
Investigated indications
- Condition
- Neoplasms
- Highest recorded phase
- 1
- Condition identifier
- EFO:0000616
- Subject identifier
- D009369
- Condition identifier
- EFO_0000616
- Condition identifier
- MONDO_0005070
- Calculated partition coefficient (XLogP)
- -1.3
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Heavy atoms
- 82
- Monoisotopic mass
- 1147.53250863
- Natural product
- No
Related records
Trials (1)
In development for (1)
- Neoplasm Phase 1